총 99건 중 99건 출력
, 5/10 페이지
-
41
-
Finerenone and Kidney Outcomes in Patients with CKD and Type 2 Diabetes: Results from FIGARO-DKD : SA-OR21
-
Bakris, George L.;
Ruilope, Luis M.;
Rossing, Peter;
Anker, Stefan D.;
Pitt, Bertram;
Filippatos, Gerasimos;
Mentenich, Nicole;
Lage, Andrea Z.;
Scheerer, Markus;
Joseph, Amer;
Agarwal, Rajiv;
Department of Medicine, University of Chicago Medicine, Chicago, IL;
;
Cardiorenal Translational Laboratory and Hypertension Unit, Madrid, Spain;
;
Steno Diabetes Center Copenhagen, Gentofte, Denmark;
;
Department of Cardiology (CVK) and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité
Universitä
tsmedizin, Berlin, Germany;
;
Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI;
;
National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital, Athens, Greece;
;
Statistics and Data Insights, Bayer AG, Wuppertal, Germany;
;
Cardiology and Nephrology Clinical Development, Bayer SA, Sã
o Paulo, Brazil;
;
Medical Affairs & Pharmacovigilance, Pharmaceuticals, Bayer AG, Berlin, Germany;
;
Cardiology and Nephrology Clinical Development, Bayer AG, Berlin, Germany;
;
Richard L. Roudebush VA Medical Center and I;
(Journal of the American Society of Nephrology : JASN,
v.32,
2021,
pp.45-45)
-
42
-
Ultrasonic Enhancement of Antibiotic Action on <i>Escherichia coli</i> Biofilms: an In Vivo Model
-
Rediske, Andrea M.;
Roeder, Beverly L.;
Brown, Maren K.;
Nelson, Jared L.;
Robison, Rachel L.;
Draper, David O.;
Schaalje, G. Bruce;
Robison, Richard A.;
Pitt, William G.;
<
!--label omitted: 1-->
Department of Microbiology,1;
<
!--label omitted: 2-->
Department of Animal Science,2;
<
!--label omitted: 1-->
Department of Microbiology,1;
<
!--label omitted: 3-->
Department of Chemical Engineering,3;
<
!--label omitted: 1-->
Department of Microbiology,1;
<
!--label omitted: 4-->
Department of Physical Education,4 and;
<
!--label omitted: 5-->
Department of Statistics,5 Brigham Young University, Provo, Utah;
<
!--label omitted: 1-->
Department of Microbiology,1;
<
!--label omitted: 3-->
Department of Chemical Engineering,3;
(Antimicrobial agents and chemotherapy,
v.43,
1999,
pp.1211-1214)
-
43
-
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial
-
Rossing, Peter;
Agarwal, Rajiv;
Anker, Stefan D.;
Filippatos, Gerasimos;
Pitt, Bertram;
Ruilope, Luis M.;
Amod, Aslam;
Marre, Michel;
Joseph, Amer;
Lage, Andrea;
Scott, Charlie;
Bakris, George L.;
Steno Diabetes Center Copenhagen, Gentofte, Denmark;
Richard L. Roudebush VA Medical Center and Indiana University, Indianapolis, Indiana, USA;
Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité
Universitä
tsmedizin, Berlin, Germany;
Department of Cardiology, National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital, Athens, Greece;
Department of Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA;
Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain;
Department of Diabetes and Endocrinology, Life Chatsmed Garden H;
(Diabetes, obesity & metabolism,
v.24,
2022,
pp.125-134)
-
44
-
Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone-a FIDELITY analysis
-
Pitt, Bertram;
Agarwal, Rajiv;
Anker, Stefan D;
Rossing, Peter;
Ruilope, Luis;
Herzog, Charles A;
Greenberg, Barry;
Pecoits-Filho, Roberto;
Lambelet, Marc;
Lawatscheck, Robert;
Scalise, Andrea;
Filippatos, Gerasimos;
Department of Medicine, University of Michigan School of Medicine , Ann Arbor, MI 48109 ,;
Richard L. Roudebush VA Medical Center and Indiana University , Indianapolis, IN 46202 ,;
Department of Cardiology (CVK) of German Heart Center Charité
;
German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité
Universitä
tsmedizin , Charité
pl. 1, 10117 Berlin ,;
Steno Diabetes Center Copenhagen , Herlev 2730 ,;
Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12 , Madrid 28041 ,;
Cardiology Division, Department of Internal Medicine, Hennepin Healthcare/University of Minnesota , Minneapolis, MN 55404 ,;
University of California San Diego , La Jolla, CA 92037 ,;
Arbor Research Collaborative for Health , Ann Arbor, MI 48108 ,;
Chrestos Concept GmbH & Co. KG , Essen 45131 ,;
Research and Development, Cardiology and Nephrology Clinical Development, Bayer AG , Berlin 13353 ,;
Pharmaceutical Development, Bayer H;
(European heart journal. Cardiovascular pharmacotherapy,
v.11,
2025,
pp.10-19)
-
45
-
Maternal and Perinatal Factors Related to Maternal-Infant Transmission of HIV-1 in the P2C2 HIV Study: The Role of EBV Shedding :
-
Pitt, Jane;
Schluchter, Mark;
Jenson, Hal;
Kovacs, Andrea;
LaRussa, Philip;
McIntosh, Kenneth;
Boyer, Pamela;
Cooper, Ellen;
Goldfarb, Johanna;
Hammill, Hunter;
Hodes, David;
Peavy, Hannah;
Sperling, Rhoda;
Tuomala, Ruth;
Shearer, William;
;
(Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
v.19,
1998,
pp.462-470)
-
46
-
EFFICACY OF FINERENONE ACCORDING TO LEFT ATRIAL SIZE IN PATIENTS WITH HEART FAILURE AND MILDLY REDUCED OR PRESERVED EJECTION FRACTION: AN ANALYSIS OF THE FINEARTS-HF TRIAL
-
Chimura, Misato;
Henderson, Alasdair;
Jhund, Pardeep S.;
Claggett, Brian;
Desai, Akshay S.;
Lam, Carolyn S.P.;
Pitt, Bertram;
Morris, Alanna A.;
Glasauer, Andrea;
Mueller, Katharina;
Scalise, Andrea;
Senni, Michele;
Shah, Sanjiv Jayendra;
Voors, Adriaan;
Zannad, Faiez;
Vaduganathan, Muthiah;
Solomon, Scott;
McMurray, John J.V.;
;
(Journal of the American College of Cardiology,
v.85,
2025,
pp.1195)
-
47
-
Physiotherapist-led exercise versus usual care (waiting-list) control for patients awaiting rotator cuff repair surgery: A pilot randomised controlled trial (POWER)
-
Littlewood, Chris;
Moffatt, Maria;
Beckhelling, Jacqueline;
Davis, Daniel;
Burden, Adrian;
Pitt, Lisa;
Lalande, Stacey;
Maddocks, Catrin;
Stephens, Gareth;
Tunnicliffe, Helen;
Pawson, Jessica;
Lloyd, James;
Manca, Andrea;
Wade, Julia;
Foster, Nadine E.;
;
(Musculoskeletal science & practice,
v.68,
2023,
pp.102874)
-
48
-
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials
-
Bansal, Shweta;
Canziani, Maria E F;
Birne, Rita;
Anker, Stefan D;
Bakris, George L;
Filippatos, Gerasimos;
Rossing, Peter;
Ruilope, Luis M;
Farjat, Alfredo E;
Kolkhof, Peter;
Lage, Andrea;
Brinker, Meike;
Pitt, Bertram;
;
(BMJ open,
v.14,
2024,
pp.e076444)
-
49
-
Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study
-
Ruilope, Luis M;
Pitt, Bertram;
Anker, Stefan D;
Rossing, Peter;
Kovesdy, Csaba P;
Pecoits-Filho, Roberto;
Pergola, Pablo;
Joseph, Amer;
Lage, Andrea;
Mentenich, Nicole;
Scheerer, Markus F;
Bakris, George L;
Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12 , Madrid , Spain;
Department of Medicine, University of Michigan School of Medicine , Ann Arbor, MI , USA;
Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies , German Centre for Cardiovascular Research Partner Site Berlin, Charité
Universitä
tsmedizin, Berlin , Germany;
Steno Diabetes Center Copenhagen , Gentofte , Denmark;
Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center , Memphis , TN, USA;
Arbor Research Collaborative for Health , Ann Arbor, MI , USA;
Renal Associates , PA, San Antonio, TX , USA;
Research and Development, Cardiology and Nephrology Clinical Development , Bayer AG, Berlin , Germany Germany;
(Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
v.38,
2023,
pp.372-383)
-
50
-
Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone - a FIDELITY analysis
-
Pitt Bertram;
Agarwal Rajiv;
Anker Stefan D;
Rossing Peter;
Ruilope Luis;
Herzog Charles A;
Greenberg Barry;
Pecoits-Filho Roberto;
Lambelet Marc;
Lawatscheck Robert;
Scalise Andrea;
Filippatos Gerasimos;
Department of Medicine, University of Michigan School of Medicine , Ann Arbor, MI ,;
Richard L. Roudebush VA Medical Center and Indiana University , Indianapolis, IN ,;
Department of Cardiology (CVK) of German Heart Center Charité, German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin , Berlin ,;
Steno Diabetes Center Copenhagen, Herlev, Denmark and Department of Clinical Medicine, University of Copenhagen , Copenhagen ,;
Faculty of Sport Sciences, European University of Madrid , Madrid ,;
Cardiology Division, Department of Internal Medicine, Hennepin Healthcare/University of Minnesota , Minneapolis, MN ,;
University of California San Diego , La Jolla, CA ,;
Arbor Research Collaborative for Health , Ann Arbor, MI ,;
Chrestos Concept GmbH &
Co. KG , Essen ,;
Research and Development, Cardiology and Nephrology Clinical Development, Bayer AG, Berlin ,;
Pharmaceutical Development, Bayer Hispania S.L., Division Pharmaceuticals , Barcelona ,;
National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital , Athens ,;
(European Heart Journal - Cardiovascular Pharmacotherapy,
v.,
2024,
)